ストックスクリーナーアプリを入手
99.15
1.00%
-1.00
前日終値:
$100.15
開ける：
$100.55
24時間の取引高:
1.70M
Relative Volume:
1.11
時価総額：
$7.91B
収益：
-
当期純損益:
$-386.19M
株価収益率:
-18.87
EPS:
-5.2547
ネットキャッシュフロー:
$-206.27M
1週間 パフォーマンス:
-1.71%
1か月 パフォーマンス:
-12.68%
6か月 パフォーマンス:
-12.73%
1年 パフォーマンス:
+1,539%
1日の値動き範囲:
$97.83
$101.49
1週間の範囲:
$95.70
$103.93
52週間の値動き範囲:
$5.69
$148.83
Abivax Adr Stock (ABVX) Company Profile
Compare ABVX vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ABVX
Abivax Adr
|
99.15 | 7.91B | 0 | -386.19M | -206.27M | -5.2547 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Abivax Adr Stock (ABVX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-16 | 開始されました | Jefferies | Buy |
| 2026-02-24 | 開始されました | Wedbush | Outperform |
| 2025-11-24 | 開始されました | Truist | Buy |
| 2025-11-06 | 開始されました | Wolfe Research | Outperform |
| 2025-10-13 | 開始されました | Barclays | Overweight |
| 2025-07-23 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2025-03-20 | 開始されました | Morgan Stanley | Equal-Weight |
| 2024-12-04 | 開始されました | JMP Securities | Mkt Outperform |
| 2024-07-29 | 開始されました | Laidlaw | Buy |
| 2024-05-20 | 開始されました | BTIG Research | Buy |
| 2024-04-29 | 開始されました | Guggenheim | Buy |
| 2024-04-29 | 開始されました | Piper Sandler | Overweight |
| 2023-11-14 | 開始されました | Leerink Partners | Outperform |
| 2023-11-14 | 開始されました | Morgan Stanley | Equal-Weight |
すべてを表示
Abivax Adr (ABVX) 最新ニュース
Abivax Soars As New Crohn’s Trial Ignites Hopes - TipRanks
Barclays Keeps Their Buy Rating on Abivax SA Sponsored ADR (ABVX) - The Globe and Mail
ABVX News | ABIVAX SA-ADR (NASDAQ:ABVX) - ChartMill
Why Abivax SA Sponsored ADR Stock Is Sinking - TipRanks
Why Abivax Shares Are Sinking Despite Trial Success - TipRanks
symbol__ Stock Quote Price and Forecast - CNN
ABIVAX SA-ADR (ABVX) Stock Chart - ChartMill
What's Going On With Abivax Stock On Thursday? - Benzinga
ABVX Technical Analysis | Trend, Signals & Chart Patterns | ABIVAX SA-ADR (NASDAQ:ABVX) - ChartMill
Abivax SA sponsored ADR (ABVX) loses 41.4% in 4 weeks, here's why a trend reversal may be around the corner - MSN
Abivax SA Sponsored ADR (ABVX) Loses 41.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
Analysts Have Conflicting Sentiments on These Healthcare Companies: Nuvalent (NUVL), Abbott Laboratories (ABT) and Abivax SA Sponsored ADR (ABVX) - The Globe and Mail
Why Abivax SA Sponsored ADR Shares Are Sinking - TipRanks
Why This Biotech Plummeted Despite Its 'Best-Case' Study - Investor's Business Daily
Truist cuts Abivax stock price target on malignancy concerns By Investing.com - Investing.com Australia
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Abivax shares sink as rare malignancy events cloud strong colitis trial data - Investing.com UK
Why Abivax SA Sponsored ADR Shares Are Sliding - TipRanks
Analysts Are Bullish on These Healthcare Stocks: Biohaven Ltd. (BHVN), Abivax SA Sponsored ADR (ABVX) - The Globe and Mail
What makes Abivax SA sponsored ADR (ABVX) a strong momentum stock: Buy now? - MSN
ABVX Q4 2025 Earnings: Wider-Than-Expected Loss Highlights Clinical-Stage Biotech ChallengesWeak Earnings Momentum - The Legal Advocate
Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (ABVX) and TG Therapeutics (TGTX) - The Globe and Mail
What Makes Abivax SA Sponsored ADR (ABVX) a Strong Momentum Stock: Buy Now? - Yahoo Finance
Analysts Are Bullish on Top Healthcare Stocks: Eli Lilly & Co (LLY), Abivax SA Sponsored ADR (ABVX) - The Globe and Mail
ABVXAbivax ADR Stock Price and Quote - Finviz
Abivax reports Q1 results, ulcerative colitis trial data - Investing.com
Abivax Shareholders Approve 2025 Accounts and Governance Resolutions at May 11 AGM - The Globe and Mail
Abivax SA Sponsored ADR (ABVX) Receives a Buy from Barclays - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Atai Beckley N.V. (ATAI), Immunic (IMUX) and Protara Therapeutics (TARA) - The Globe and Mail
Brummer Multi Strategy AB Acquires Shares of 14,375 Abivax SA Sponsored ADR $ABVX - MarketBeat
Abivax SA Sponsored ADR (ABVX) Receives a Rating Update from a Top Analyst - The Globe and Mail
Abivax SA Sponsored ADR $ABVX Shares Acquired by Nan Fung Trinity HK Ltd. - MarketBeat
Abivax Buys Back $90 Million in Royalties via $45 Million ADS Offering, Keeps Cash Runway to Q4 2027 - The Globe and Mail
Number of shareholders of Abivax SA Sponsored ADR – TRADEGATE:2X10 - TradingView
Why Abivax SA Sponsored ADR Shares Are Under Pressure - TipRanks
Jennison Associates LLC Buys Shares of 127,907 Abivax SA Sponsored ADR $ABVX - MarketBeat
Pictet Asset Management Holding SA Sells 72,387 Shares of Abivax SA Sponsored ADR $ABVX - MarketBeat
Total Clarity Wealth Management Inc. Acquires Shares of 9,245 Abivax SA Sponsored ADR $ABVX - MarketBeat
Abivax SA Sponsored ADR (NASDAQ:ABVX) Sees Large Drop in Short Interest - MarketBeat
Why Abivax SA Sponsored ADR Shares Keep Sliding - TipRanks
ABVX soars pre-market on reports of $17.5 billion Eli Lilly takeover interest - MSN
UBS Group AG Has $596.59 Million Stock Holdings in Abivax SA Sponsored ADR $ABVX - MarketBeat
China Universal Asset Management Co. Ltd. Purchases Shares of 11,619 Abivax SA Sponsored ADR $ABVX - MarketBeat
Abivax SA Sponsored ADR (NASDAQ:ABVX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX) and Regeneron (REGN) - The Globe and Mail
Abivax Publishes Preparatory Documents for May 11, 2026 General Meeting - TipRanks
Tudor Investment Corp ET AL Buys New Position in Abivax SA Sponsored ADR $ABVX - MarketBeat
Why Abivax SA Sponsored ADR Shares Are Surging - TipRanks
Abivax Adr (ABVX) 財務データ
収益
当期純利益
現金流量
EPS
0.74%
1.44%
大文字化:
|
ボリューム (24 時間):